What are the syndromes of behavioral and psychological symptoms of dementia? Dahkki Mcshane, R

Effect of an educational video on the accuracy of surrogate decisions: the case of electroconvulsive therapy. Dahkki Pieroni, S, Mcshane, R

Clioquinol for the treatment of Alzheimer's Disease. Dahkki Jenagaratnam, L, Mcshane, R

Meta-analysis of memantine: summary and commentary on the Cochrane Collaboration's systematic review. Dahkki Mcshane, R, Schneider, L

Non-pharmacological interventions for wandering of people with dementia in the domestic setting Dahkki Hermans, D, Hla, H, Mcshane, R

Metal protein attenuating compounds for the treatment of Alzheimer's dementia Dahkki Sampson, E, Jenagaratnam, L, Mcshane, R

Memantine for dementia. Dahkki Mcshane, R, Areosa Sastre, A, Minakaran, N

Lack of evidence for the efficacy of memantine in mild Alzheimer disease Dahkki Schneider, L, Dagerman, K, Higgins, J, Mcshane, R

Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease. Dahkki Nagy, Z, Combrinck, M, Budge, M, Mcshane, R

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Dahkki Rolinski, M, Fox, C, Maidment, I, Mcshane, R

Issues in drug treatment for Alzheimer's disease. Dahkki Mcshane, R, Keene, J, Fairburn, C, Jacoby, R, Hope, T

Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. Dahkki Williams, S, Williams, J, Combrinck, M, Christie, S, Smith, A, Mcshane, R

Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies. Dahkki Gustavsson, A, Van Der Putt, R, Jönsson, L, Mcshane, R

Alpha-synuclein pathology in the olfactory pathways of dementia patients. Dahkki Hubbard, P, Esiri, M, Reading, M, Mcshane, R, Nagy, Z

Effectiveness of acetylcholinesterase inhibitors: diagnosis and severity as predictors of response in routine practice. Dahkki Van Der Putt, R, Dineen, C, Janes, D, Series, H, Mcshane, R

Willingness-to-pay for reductions in care need: estimating the value of informal care in Alzheimer's disease. Dahkki Gustavsson, A, Jönsson, L, Mcshane, R, Boada, M, Wimo, A, Zbrozek, A

Anosmia in subjects with dementia is associated with Lewy pathology in the olfactory pathways Dahkki Hubbard, P, Esiri, M, Smith, A, King, E, Reading, M, Nagy, Z, Mcshane, R

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). Dahkki Ballard, C, Lana, M, Theodoulou, M, Douglas, S, Mcshane, R, Jacoby, R, Kossakowski, K, Yu, L, Juszczak, E

The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Dahkki Ballard, C, Hanney, M, Theodoulou, M, Douglas, S, Mcshane, R, Kossakowski, K, Gill, R, Juszczak, E, Yu, L, Jacoby, R

A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical ou... Dahkki Ballard, C, Thomas, A, Fossey, J, Lee, L, Jacoby, R, Lana, M, Bannister, C, Mcshane, R, Swann, A, Juszczak, E, O'Brien, J